Vontobel Says Democratic Midterm Win Could Ease Headwinds for Drugmakers
Vontobel analyst Jean-Philippe Bertschy says Democratic control of both U.S. chambers could ease a policy headwind for Swiss pharmaceutical companies. He says it could also increase scrutiny of Trump's international drug-pricing deal.